Tiếp theo

Tự chạy

2020 Targeting ALK - From Discovery to Frontline Treatment

6 Lượt xem • 07/30/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy